Global Blood Grouping Gel Card Market Growth 2025-2031

The global Blood Grouping Gel Card market size is predicted to grow from US$ 77.3 million in 2025 to US$ 116 million in 2031; it is expected to grow at a CAGR of 7.0% from 2025 to 2031.

Blood Grouping Gel Card is a disposable card or device used in blood typing and blood grouping tests. The gel card method involves mixing a patient's blood sample with specific reagents and observing the agglutination patterns in the gel matrix to determine the blood group and compatibility for transfusion purposes.

Market Overview

Blood grouping gel cards are used in the process of ABO and Rh blood typing, which is crucial for ensuring the compatibility of blood donations with recipients during transfusions. The market for these gel cards is driven by several factors, including the increasing demand for safe blood transfusions, advancements in medical technology, and the global expansion of healthcare infrastructure.

Key Market Drivers

Rising Demand for Safe Blood Transfusions:

With the increasing incidence of diseases and accidents, the demand for blood transfusions has surged.

Ensuring the safety and compatibility of blood donations is paramount, which has led to a growing demand for blood grouping gel cards.

Advancements in Medical Technology:

Continuous improvements in diagnostic technologies have led to the development of more accurate and efficient blood grouping methods.

Gel cards are one such technology that offers rapid and reliable results, contributing to their growing popularity.

Global Expansion of Healthcare Infrastructure:

As healthcare infrastructure expands worldwide, more clinical laboratories and blood banks are being established.

This expansion has created a significant demand for blood grouping gel cards.

Market Challenges

Regulatory Hurdles:

The medical device industry is subject to stringent regulatory requirements.

Manufacturers of blood grouping gel cards must navigate complex regulatory landscapes to ensure their products meet safety and efficacy standards.

Conclusion

The Blood Grouping Gel Card market is a growing segment of the healthcare industry. Driven by factors such as the increasing demand for safe blood transfusions, advancements in medical technology, and the global expansion of healthcare infrastructure, this market is poised for significant growth. However, manufacturers must navigate regulatory hurdles and compete in a highly competitive landscape to succeed. As new blood typing technologies emerge, manufacturers will need to stay abreast of these developments to ensure their products remain relevant and competitive.

LP Information, Inc. (LPI) ' newest research report, the “Blood Grouping Gel Card Industry Forecast” looks at past sales and reviews total world Blood Grouping Gel Card sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood Grouping Gel Card sales for 2025 through 2031. With Blood Grouping Gel Card sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Grouping Gel Card industry.

This Insight Report provides a comprehensive analysis of the global Blood Grouping Gel Card landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Grouping Gel Card portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Grouping Gel Card market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Grouping Gel Card and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Grouping Gel Card.

This report presents a comprehensive overview, market shares, and growth opportunities of Blood Grouping Gel Card market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Six Columns
Eight Columns

Segmentation by Application:
Hospital
Laboratory
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Grifols
Fortress Diagnostics
Ortho Clinical Diagnostics
ISLAB
Biorex Diagnostics
Bio-Rad
Tulip Diagnostics
KangJia
Aikang MedTech
Zhuhai Ideal Biotech
BSBE

Key Questions Addressed in this Report

What is the 10-year outlook for the global Blood Grouping Gel Card market?

What factors are driving Blood Grouping Gel Card market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Blood Grouping Gel Card market opportunities vary by end market size?

How does Blood Grouping Gel Card break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.